News Conference News EuroPCR 2015 DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device Yael L. Maxwell May 20, 2015
News Conference News ACC 2015 ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG Yael L. Maxwell March 16, 2015
News Conference News ACC 2015 DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume Yael L. Maxwell March 16, 2015
News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015
News Conference News TCT 2014 Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy September 16, 2014
News Conference News ESC 2014 Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device Todd Neale August 31, 2014
News Conference News AHA 2013 Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients Yael L. Maxwell November 20, 2013
News Conference News TCT 2013 BOSS: Sodium Bicarbonate May Protect Heart After Coronary Angiography October 29, 2013
News Conference News EuroPCR 2013 Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR Jason Kahn May 24, 2013
News Conference News SCAI 2013 Live TAVR Cases Pose No Additional Risk for Patients L.A. McKeown May 10, 2013
News Conference News SCAI 2013 POSEIDON: Sliding-Scale Hydration Prevents CIN, Adverse Events at 6 Months Yael L. Maxwell May 09, 2013
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Conference News TCT 2012 Registries Show Low Complication Rates With New Heart Valves October 23, 2012
News Conference News EuroPCR 2012 TAVR Studies Tease Out Influences on Clinical Outcome Caitlin E. Cox May 18, 2012
News Conference News ACC 2012 CORONARY Bypass Shows Similar Results Whether On-Pump or Off Jason Kahn March 26, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012